bSys

bSys is a specialized Swiss contract research organization (CRO) focused on ion channel drug discovery and safety pharmacology. The company provides high-quality electrophysiology services, including automated and manual patch-clamp assays, to support pharmaceutical and biotech clients worldwide. bSys offers a vast library of validated ion channel cell lines and provides comprehensive cardiac safety screening, such as hERG testing and CiPA-compliant assays. Their expertise spans multiple therapeutic areas, including cardiovascular, central nervous system (CNS), and metabolic diseases. By combining advanced technology with deep biological insights, bSys facilitates the identification and optimization of drug candidates targeting complex membrane proteins.